Tarsus Pharmaceuticals, Inc. (TARS) Earnings
NASDAQ·Healthcare·Biotechnology
$67.75
-1.25%
Mkt Cap $3.50B
EPS — Estimate vs Actual
Mkt Cap
$3.50B
P/E
—
Fwd P/E
—
P/S
6.55
Rev TTM
—
EPS TTM
-$1.14
NASDAQ·Healthcare·Biotechnology
$67.75
-1.25%
Mkt Cap $3.50B
Mkt Cap
$3.50B
P/E
—
Fwd P/E
—
P/S
6.55
Rev TTM
—
EPS TTM
-$1.14